ESG and Impact

People

Our people play a crucial part in shaping our social responsibility, fostering a diverse and inclusive culture, and driving ethical business practices

Our ESG strategy is esssential for attracting top talent to ensure long-term resilience and positive societal impact

Innovation

We place great importance in using innovative approaches in our business and in our AI to drive true commercial and societal benefit

By prioritizing ESG factors we believe we are driving innovation that addresses global and social challenges

Community

We aspire to contribute positively to our communities, thereby aligning with the evolving expectations of stakeholders and investors.

We are constantly learning from and fortunate to benefit from the experience of others to refine our practices and operations as well as giving back to take others forward

Environment

Talking Medicines prioritizes environmental responsibility to contribute toward sustainability and mitigate climate risks. We also aim to align with the growing awareness of eco-conscious practices alongside our stakeholder partners

We recognize the importance of good environmental practice and understand that it is crucial for ethical business conduct

Finance

Integrating finance into our ESG framework enhances our corporate reputation and attracts socially responsible investors and partners, fostering sustainable and responsible business practices

Governance

Strong governance practices not only safeguard against potential risks but also ensure transparent communication with stakeholders, reinforcing the company’s commitment to social responsibility

Effective governance is integral to building resilience, maintaining trust, and fostering sustainable business practices

Impact

Impact refers to the measurable and often transformative effects that an action, initiative, or entity has on various aspects of society, the environment, or the economy

Talking Medicines have a strategy on social impact that includes the key team, community, and stakeholder partners including Patients and Patient organisations